Laura E Baldassari

8PUBLICATIONS
16CO-AUTHORS
Gene and molecular therapyAllergyMedicinal and biomolecular chemistry not elsewhere classifiedAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 10, 2026
FDA's Approval Summary of the First Biosimilar to Natalizumab for the Treatment of Multiple Sclerosis and Crohn's Disease.

|Oct 27, 2025
Anaphylaxis and glatiramer acetate.

Tiffany B Kim, Jenni Yoon Lee, Allen Brinker

|Feb 11, 2025
Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety risk.

Tiffany Kim, Allen Brinker, David Croteau

|Sep 14, 2023
Immune-mediated colitis associated with ocrelizumab: A new safety risk.

Tiffany Kim, Allen Brinker, David Croteau

|Nov 18, 2021
The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective.

Laura E Baldassari, Mike P Wattjes, Irene C M Cortese

|Nov 15, 2019
Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation.

Laura E Baldassari, Sarah M Planchon, Robert A Bermel

Pageof 2

Frequent Collaborators

2 joint publications

Paul R Lee

2 joint publications

Jenny Feng

2 joint publications

Sarah M Planchon

2 joint publications

Daniel Ontaneda